Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

被引:19
|
作者
Chinwong, Dujrudee [1 ,2 ]
Patumanond, Jayanton [3 ]
Chinwong, Surarong [1 ]
Siriwattana, Khanchai [4 ]
Gunaparn, Siriluck [5 ]
Hall, John Joseph [6 ]
Phrommintikul, Arintaya [5 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pharmaceut Care, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Clin Epidemiol Program, Chiang Mai 50200, Thailand
[3] Thammasat Univ, Fac Med, Ctr Excellence Appl Epidemiol, Pathum Thani, Thailand
[4] Nakornping Hosp, Div Med, Chiang Mai, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50200, Thailand
[6] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Callaghan, NSW 2308, Australia
关键词
LDL-C goal attainment; statins; potency statins; high risk; propensity score; LIPID-LOWERING TREATMENT; HIGH-RISK; HYPERCHOLESTEROLEMIC PATIENTS; LDL-C; MEDICATION ADHERENCE; CLINICAL-PRACTICE; PROPENSITY SCORE; ACHIEVEMENT; SIMVASTATIN; EZETIMIBE;
D O I
10.2147/TCRM.S75608
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Elevated low-density lipoprotein cholesterol (LDL-C) is associated with an increased risk of coronary artery disease. Current guidelines recommend an LDL-C target of <70 mg/dL (<1.8 mmol/L) for acute coronary syndrome (ACS) patients, and the first-line treatment to lower lipids is statin therapy. Despite current guidelines and the efficacious lipid-lowering agents available, about half of patients at very high risk, including ACS patients, fail to achieve their LDL-C goal. This study assessed LDL-C goal attainment according to use of high and low potency statins in routine practice in Thailand. Methods: A retrospective cohort study was performed by retrieving data from medical records and the electronic hospital database for a tertiary care hospital in Thailand between 2009 and 2011. Included were ACS patients treated with statins at baseline and with follow-up of LDL-C levels. Patients were divided into high or low potency statin users, and the proportion reaching the LDL-C goal of. 70 mg/dL was determined. A Cox proportional hazard model was applied to determine the relationship between statin potency and LDL-C goal attainment. Propensity score adjustment was used to control for confounding by indication. Results: Of 396 ACS patients (60% males, mean age 64.3 +/- 11.6 years), 229 (58%) were treated with high potency statins and 167 (42%) with low potency statins. A quarter reached their target LDL-C goal (25% for patients on high potency statins and 23% on low potency statins). High potency statins were not associated with increased LDL-C goal attainment (adjusted hazards ratio 1.22, 95% confidence interval 0.79-1.88; P=0.363). Conclusion: There was no significant effect of high potency statins on LDL-C goal attainment. Moreover, this study showed low LDL-C goal attainment for patients on either low or high potency statins. The reasons for the low LDL-C goal attainment rate warrants further investigation.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 50 条
  • [31] Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention
    Achim Leo Burger
    Nora Beran
    Edita Pogran
    Christoph C. Kaufmann
    David Zweiker
    Marie Muthspiel
    Benjamin Panzer
    Bernhard Jäger
    Miklos Rohla
    Kurt Huber
    Wiener klinische Wochenschrift, 2023, 135 : 674 - 679
  • [32] Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention
    Burger, Achim Leo
    Beran, Nora
    Pogran, Edita
    Kaufmann, Christoph C.
    Zweiker, David
    Muthspiel, Marie
    Panzer, Benjamin
    Jaeger, Bernhard
    Rohla, Miklos
    Huber, Kurt
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (23-24) : 674 - 679
  • [33] Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy
    Ballantyne, Christie M.
    McKenney, James M.
    MacDougall, Diane E.
    Margulies, Janice R.
    Robinson, Paula L.
    Hanselman, Jeffrey C.
    Lalwani, Narendra D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (12): : 1928 - 1933
  • [34] Statin therapy and reductions in low-density lipoprotein cholesterol: Initial clinical data on the potent new statin rosuvastatin
    Olsson, AG
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (5A): : 33B - 36B
  • [35] Ezetimibe added to ongoing statin therapy:: Incremental reductions in low-density lipoprotein cholesterol are independent of statin efficacy
    Mata, P
    Roth, E
    Masana, L
    Pintó, X
    Troxell, J
    Allen, C
    Gumbiner, B
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 135 - 135
  • [36] Addition of ezetimibe to ongoing statin therapy: incremental reduction in low-density lipoprotein cholesterol is independent of statin type
    Mata, P
    Gumbiner, B
    Musliner, T
    Quinto, K
    Cho, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 19 - 19
  • [37] Getting there: Statin plus ezetimibe for low-density lipoprotein cholesterol
    Hurley, DL
    Isley, WL
    MAYO CLINIC PROCEEDINGS, 2005, 80 (05) : 585 - 586
  • [38] Combination Therapy With Ezetimibe/Simvastatin Versus Statin Monotherapy for Low-Density Lipoprotein Cholesterol Reduction and Goal Attainment in a Real-World Clinical Setting
    Friedman, Howard S.
    Rajagopalan, Srinivasan
    Barnes, Jaime P.
    Roseman, Hal
    CLINICAL THERAPEUTICS, 2011, 33 (02) : 212 - 224
  • [39] LOW LIPOPROTEIN CHOLESTEROL GOAL ATTAINMENT IN DYSLIPIDEMIC PATIENTS WITH EXISTING STATIN THERAPY: A CHART EXTRACTION-BASED APPROACH
    Ivanova, J.
    Frois, C.
    Bae, J. P.
    Boykin, S. D.
    Mccracken, R.
    Molife, C.
    Waldman, T.
    Zhao, Z.
    VALUE IN HEALTH, 2011, 14 (07) : A389 - A389
  • [40] Benefit of Early Statin Therapy in Patients With Acute Myocardial Infarction Who Have Extremely Low Low-Density Lipoprotein Cholesterol
    Lee, Ki Hong
    Jeong, Myung Ho
    Kim, Ha Mi
    Ahn, Youngkeun
    Kim, Jong Hyun
    Chae, Shung Chull
    Kim, Young Jo
    Hur, Seung Ho
    Seong, In Whan
    Hong, Taek Jong
    Choi, Dong Hoon
    Cho, Myeong Chan
    Kim, Chong Jin
    Seung, Ki Bae
    Chung, Wook Sung
    Jang, Yang Soo
    Rha, Seung Woon
    Bae, Jang Ho
    Cho, Jeong Gwan
    Park, Seung Jung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (16) : 1664 - 1671